Suppr超能文献

消毒剂的杀分枝杆菌测试:最新进展

Mycobactericidal testing of disinfectants: an update.

作者信息

Sattar S A, Best M, Springthorpe V S, Sanani G

机构信息

Faculty of Medicine, University of Ottawa, Ontario, Canada.

出版信息

J Hosp Infect. 1995 Jun;30 Suppl:372-82. doi: 10.1016/0195-6701(95)90041-1.

Abstract

Tuberculosis, a major killer in developing countries, is on the rise again in industrialized nations. AIDS, increased use of immunosuppression and the emergence of multiple drug-resistant Mycobacterium tuberculosis (MDR-TB) have further enhanced its significance. TB is projected to cause 3.5 million deaths per year by 2000. Also, other types of mycobacteria are being incriminated in human infections with increasing frequency. Thus, the enhanced risk of nosocomial and iatrogenic spread of mycobacteria is forcing a review of infection control in general and claims of mycobactericidal activity of disinfectants in particular. Mycobacteria are more resistant to disinfection than enveloped viruses and other types of vegetative bacteria, but a proper comparison with non-enveloped viruses requires more data. Flaws in currently used protocols for mycobacterial activity are: (i) a lack of proper quantitation; (ii) unrealistically long contact times at higher than ambient temperatures; (iii) absence of a suitable organic load; (iv) ineffective neutralizers; (v) unsuitable surrogates for M. tuberculosis; (vi) improper recovery media; and (vii) inappropriate types of carriers. Furthermore, we have recently found a product meant for 14 day reuse to become non-mycobactericidal after only a week under actual use in an endoscopy unit. These considerations make the available data on product efficacy unreliable, especially in view of the increasing threat from MDR-TB. Recent findings suggest that the use of Mycobacterium terrae as a surrogate, better recovery media, flat surfaces as carriers, elimination of neutralizers, proper removal of cell clumps and a required > or = 4 log10 reduction in the number of colony forming units of the test bacterium after disinfectant treatment should make mycobacteridal tests more precise and reliable, thus making product registration and selection easier. There is also an urgent need to develop standardized protocols to determine the mycobactericidal activity of disinfectants under conditions of reuse.

摘要

结核病在发展中国家是主要杀手,在工业化国家也再度呈上升趋势。艾滋病、免疫抑制的更多使用以及多重耐药结核分枝杆菌(MDR-TB)的出现进一步凸显了其重要性。预计到2000年,结核病每年将导致350万人死亡。此外,其他类型的分枝杆菌在人类感染中出现的频率越来越高。因此,分枝杆菌在医院内和医源性传播风险的增加,促使人们对总体感染控制进行重新审视,尤其是对消毒剂的杀分枝杆菌活性提出了要求。分枝杆菌比包膜病毒和其他类型的营养细菌对消毒更具抗性,但与无包膜病毒进行恰当比较需要更多数据。目前用于测试分枝杆菌活性的方案存在以下缺陷:(i)缺乏适当的定量;(ii)在高于环境温度下接触时间过长,不切实际;(iii)缺乏合适的有机负荷;(iv)中和剂无效;(v)不适合作为结核分枝杆菌的替代物;(vi)回收培养基不合适;(vii)载体类型不当。此外,我们最近发现,一种设计可重复使用14天的产品,在内镜检查科室实际使用仅一周后就失去了杀分枝杆菌的能力。这些因素使得有关产品功效的现有数据不可靠,特别是考虑到多重耐药结核杆菌带来的日益增加的威胁。最近的研究结果表明,使用地分枝杆菌作为替代物、更好的回收培养基、以平面作为载体、去除中和剂、适当去除细胞团块以及消毒剂处理后测试细菌的菌落形成单位数量减少≥4个对数级,应能使杀分枝杆菌测试更加精确和可靠,从而使产品注册和选择更加容易。迫切需要制定标准化方案,以确定消毒剂在重复使用条件下的杀分枝杆菌活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验